Nonpeptide angiotensin II receptor antagonists: the discovery of DMP 581 and DMP 811
Authors:
- 1 January 1994
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 4 (1) , 63-68
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- The preparation of (perfluoroalkyl)imidazoles as nonpeptide angiotensin II receptor antagonistsBioorganic & Medicinal Chemistry Letters, 1993
- The discovery of DuP 753, a potent, orally active nonpeptide angiotensin II receptor antagonistMedicinal Research Reviews, 1992
- Nonpeptide angiotensin II receptor antagonists: the discovery of a series of N-(biphenylylmethyl)imidazoles as potent, orally active antihypertensivesJournal of Medicinal Chemistry, 1991
- Proximal nephron and renal effects of DuP 753, a nonpeptide angiotensin II receptor antagonistKidney International, 1990
- Part VI. Nonpeptide angiotensin II receptor antagonists: N-[(benzyloxy)benzyl]imidazoles and related compounds as potent antihypertensivesJournal of Medicinal Chemistry, 1990
- The discovery of potent nonpeptide angiotensin II receptor antagonists: a new class of potent antihypertensivesJournal of Medicinal Chemistry, 1990
- The renin-angiotensin systemTrends in Pharmacological Sciences, 1987
- Angiotensin Receptor Is a Desirable Locus for Physiologically Specific Inhibition of the Renin-Angiotensin SystemJournal of Cardiovascular Pharmacology, 1985
- A new class of angiotensin-converting enzyme inhibitorsNature, 1980
- Design of Specific Inhibitors of Angiotensin-Converting Enzyme: New Class of Orally Active Antihypertensive AgentsScience, 1977